AzTrials
AzTrials

Osteosynthesis of Fibula Fractures With a Locked Thin PlateOFFPAVNCT07365202

Osteosynthesis of Fibula Fractures With a Locked Thin Plate

An observational study of Osteosynthesis of Fibula Fractures With a Locked Thin Plate, run by University Hospital, Grenoble at 1 site in France.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Ankle fractures represent about 10% of all fractures and are common in both elderly patients with comorbidities and younger polytraumatized individuals. Traditional fibular osteosynthesis uses open plating, which carries up to a 20% complication rate, mainly due to skin issues. Read more about this study

Who is it for?
Ages 18 to 100 years
How many people
40 participants
Where
1 siteFrance
Study dates
15 Jan 2026to 15 Dec 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 100 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: In this study, all adult patients treated for a lateral malleolus fracture with an anatomically contoured plate, either alone or associated with a bimalleolar, trimalleolar, or tibial pilon injury in the orthopedic and trauma department at Grenoble University Hospital, between 04/01/2025 (the date of first use of the contoured plate) and 1 year post-surgery, may be selected. Epidemiological data, preoperative management, fracture types according to the Weber and AO/OTA classifications [12], operative data, as well as radiological data are collected and analyzed.

Who may be able to join

  • Adult patient at the time of injury
  • Patient who underwent surgery with a low-profile plate, including:
  • Isolated lateral malleolar fracture treated with a low-profile anatomical plate
  • Lateral malleolar fracture associated with a bimalleolar injury treated with a low-profile anatomical plate
  • Lateral malleolar fracture associated with a trimalleolar injury treated with a low-profile anatomical plate
  • Lateral malleolar fracture associated with a tibial pilon injury treated with a low-profile anatomical plate
Show all 9Show fewer
  • Standard preoperative radiographs (ankle AP and lateral views)
  • Standard postoperative radiographs (ankle AP and lateral views)
  • No objection to participation in the study

Who cannot join

  • Individuals deprived of liberty by judicial or administrative decision, or individuals under legal protection
  • Patients with dementia preventing the collection of secondary clinical outcome measures (Olerud and Molander score, VAS, EFAS score, EQ-5D-5L)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Mehdi BOUDISSA, Pr contact

0033476763275

mboudissa@chu-grenoble.fr

Sarah KASSAR-UNEISI, Pharm D contact

0033476767524

suneisi@chu-grenoble.fr

France1 site
  • Grenoble Alpes university Hospital

    La Tronche, 38700

    Sarah KASSAR-UNEISI, Pharm D, 0033476767524, suneisi@chu-grenoble.fr

    mboudissa@chu-grenoble.fr

Other trials in France

About this study

Official title: Osteosynthesis of Fibula Fractures With a Locked Thin Plate: a Single-center Retrospective Series.

Ankle fractures represent about 10% of all fractures and are common in both elderly patients with comorbidities and younger polytraumatized individuals. Traditional fibular osteosynthesis uses open plating, which carries up to a 20% complication rate, mainly due to skin issues. These complications are more frequent in patients with diabetes, vascular or neurological disease, obesity, or tobacco/alcohol use, as well as in open fractures or fracture-dislocations. Standard plates can also cause long-term discomfort due to their thickness, often requiring removal.

Recent meta-analyses show that fibular nailing and thin one-third tubular plates result in fewer complications than anatomical plates, while maintaining similar bone-healing rates (97-100%). New thinner locked plates (2.8 mm) have been developed to reduce skin risks and discomfort; biomechanical studies suggest superior strength. Clinical research is needed to confirm their effectiveness and tolerance.

Read the detailed description

Ankle fractures account for up to 10% of all fractures. They are the third most common fracture site in adults, with nearly 169 cases per 100,000 inhabitants per year . These injuries affect a heterogeneous population, including elderly patients who often have comorbidities as well as younger polytraumatized individuals. Fibular osteosynthesis is traditionally performed by open reduction and internal fixation using plates with screws, either locked or non-locked. The longitudinal approach required for osteosynthesis carries risks, with complication rates reaching up to 20% in some series, the most common being skin complications related to the necessary incision .

The rate of cutaneous complications is associated with age, diabetes, peripheral vascular and neurological diseases, obesity, and alcohol or tobacco use . Moreover, an open injury or a fracture-dislocation further increases this risk. In addition, the plates traditionally used have a certain thickness that can cause long-term discomfort, often requiring hardware removal after bone healing. Recent meta-analyses published show a superiority of fibular nailing-and even simple one-third tubular plates-over so-called "anatomical" plates in terms of complications (patient discomfort, infection, and wound-healing issues), due to the smaller profile of the implants. Bone-healing rates remain comparable across different fixation methods and range from 97% to 100% in recent meta-analyses.

Recently, new implants have been developed to reduce skin risks and discomfort related to implant thickness. These thinner locked plates have a thickness of 2.8 mm (compared with an average of 3.5 mm for competing systems). A recent biomechanical study demonstrated their superior mechanical resistance . A clinical study would be useful to confirm these results in terms of bone healing and tolerance (cutaneous tolerance and implant-related discomfort).

Study designe:Descriptive single-center historico-prospective observational cohort study without a control group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Evaluate the clinical of patients treated for fixation of an external malleolus fracture, whether isolated or associated with a bi malleolar, tri malleolar, or tibial pilon injury, using a low profile anatomical plate.

    Achieving consolidation without skin complications and without the need for hardware removal.

    • Consolidation is defined as the absence of visible fractures on standard anteroposterior and lateral ankle X-rays at 6 months post-operation.
    • The absence of skin complications is defined as wound healing achieved within the expected theoretical healing period (1 month).
    • The absence of a need for hardware removal is defined as the lack of necessity, one year after surgery, for the patient to have the hardware removed due to discomfort caused by the implant.

    Measured: 1 year

  2. Evaluate radiological outcomes of patients treated for fixation of an external malleolus fracture, whether isolated or associated with a bi malleolar, tri malleolar, or tibial pilon injury, using a low profile anatomical plate.

    Achieving consolidation without skin complications and without the need for hardware removal.

    • Consolidation is defined as the absence of visible fractures on standard anteroposterior and lateral ankle X-rays at 6 months post-operation.
    • The absence of skin complications is defined as wound healing achieved within the expected theoretical healing period (1 month).
    • The absence of a need for hardware removal is defined as the lack of necessity, one year after surgery, for the patient to have the hardware removed due to discomfort caused by the implant.

    Measured: 1 year

Secondary outcomes (6)
  1. Assessment of the quality of radiological reduction

    Radiological criteria of McLenann et al (assessment of the quality of radiological reduction)

    Measured: 1 year

  2. Evaluation of clinical outcomes: Ankle functional scores

    Clinical scores of Olerud and Molander (ankle function score)

    Measured: 1 year

  3. Evaluation of clinical outcomes: Pain

    Clinical scores of VAS (visual analog scale) , from 0 to 10 (0-10) 0 non pain 10 extreme pain

    Measured: 1 year

  4. Evaluation of clinical outcomes: Ankle functional scores

    Clinical scores of EFAS (ankle function score)

    Measured: 1 year

  5. Evaluation of clinical outcomes: Quality of life

    Clinical scores of EQ5D-5L (quality of life)

    Measured: 1 year

  6. Evaluation of complications

    Complications: re-operation(s), infection, healing disorders, secondary displacement, discomfort from osteosynthesis material, removal of osteosynthesis material

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Jan 2026
  2. Study start15 Jan 2026 (estimated)
  3. Primary completion15 Dec 2026 (estimated)
  4. Study completion15 Dec 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Other
Enrolment
40 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07365202
Sponsor's protocol ID
38RC25.0227
Acronym
OFFPAV
Status last verified
Jan 2026
First submitted
6 Jan 2026
Last updated
26 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Osteosynthesis of Fibula Fractures With a Locked Thin Plate, run by University Hospital, Grenoble at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Mehdi BOUDISSA, Pr (0033476763275, mboudissa@chu-grenoble.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Evaluate the clinical of patients treated for fixation of an external malleolus fracture, whether isolated or associated with a bi malleolar, tri malleolar, or tibial pilon injury, using a low profile anatomical plate. (time frame: 1 year). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in